Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene amplification and tumor progression

O Brison1

  • 1Laboratoire d'Oncologie Moléculaire, URA 1158 CNRS Institut Gustave Roussy, Villejuif, France.

Biochimica Et Biophysica Acta
|May 25, 1993
PubMed
Summary

Proto-oncogene amplification in human tumors, particularly erbB, ras, and myc families, drives tumor progression by increasing gene expression. This amplification, specific to tumor cells, enhances their response to growth stimuli and contributes to tumorigenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line.

Cytogenetic and genome research·2009
Same author

Deregulated expression of the keratin 18 gene in human colon carcinoma cells.

Somatic cell and molecular genetics·2001
Same author

T-cell lymphoma with eosinophilia of donor origin occurring 12 years after allogeneic bone marrow transplantation for myeloma.

Transplantation·2001
Same author

A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.

Molecular and cellular biochemistry·2000
Same author

Regulation of FGF-3 gene expression in tumorigenic and non-tumorigenic clones of a human colon carcinoma cell line.

The Journal of biological chemistry·2000
Same author

Sequence analysis of the transcription control region upstream of the human FGF-3 gene.

DNA sequence : the journal of DNA sequencing and mapping·2000

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Proto-oncogenes are frequently amplified in human tumor cells.
  • Gene amplification conferring drug resistance is common in vitro but rare in human tumors.
  • Amplified proto-oncogenes in tumors typically belong to the erbB, ras, myc families, or the 11q13 locus.

Purpose of the Study:

  • To investigate the role of proto-oncogene amplification and overexpression in human tumor progression.
  • To understand the functional consequences of proto-oncogene amplification in tumorigenesis.
  • To identify the specific proto-oncogenes involved in tumor development and progression.

Main Methods:

  • Analysis of gene amplification patterns in human tumor cells.
  • Assessment of proto-oncogene expression levels in tumor samples.
  • Correlation of proto-oncogene amplification with tumor phenotype and patient outcomes.
  • Functional studies on the role of proto-oncogene proteins in cell signaling and proliferation.

Main Results:

  • Proto-oncogene amplification is specific to tumor cells and selected for during tumor growth.
  • Amplification of erbB, ras, and myc families often leads to overexpression, supporting their role in tumor progression.
  • The prad1 gene is a candidate for driving amplification at the 11q13 locus.
  • N-myc and L-myc amplifications are associated with specific tumor types (neuronal/neuroendocrine and lung carcinomas, respectively).
  • Overexpression of amplified proto-oncogenes can confer a transformed or tumorigenic phenotype.
  • N-myc amplification in neuroblastomas may contribute to metastasis via MHC Class I antigen down-modulation.

Conclusions:

  • Proto-oncogene amplification and subsequent overexpression play a significant role in human tumor progression.
  • These amplified genes encode proteins involved in critical cellular processes like signal transduction and proliferation.
  • Understanding the function of amplified proto-oncogene proteins is crucial for developing targeted cancer therapies.

Related Experiment Videos